Symbols

SAGE(Delisted)

Sage Therapeutics·NASDAQ

--(--)

SAGE fundamentals

SAGE Q3 2017 Earnings

Sage Therapeutics (SAGE) released its earnings on Nov 2, 2017: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.

Revenue / YoY

EPS / YoY

Report date

Nov 2, 2017

Earnings

EPS

Revenue

Revenue & Expenses

SAGE has released its 2025 Q2 earnings report, with revenue of 31.66M, reflecting a YoY change of 265.84%, and net profit of -49.65M, showing a YoY change of 51.73%. The Sankey diagram below clearly presents SAGE's revenue sources and cost distribution.

Key Indicators

Sage Therapeutics (SAGE) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Sage Therapeutics (SAGE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Sage Therapeutics (SAGE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Sage Therapeutics (SAGE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Sage Therapeutics (SAGE) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Sage Therapeutics (SAGE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data